Collection of Blood From Patients With Pancytopenia
Lymphocytapheresis of Patients With Pancytopenia
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT00001214, this observational or N/A phase trial focuses on Pancytopenia and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 19 times since 1986, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
19 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Sep 2020 — Jan 2021 [monthly]
Completed
-
Aug 2020 — Sep 2020 [monthly]
Completed
▶ Show 14 earlier versions
-
Jul 2020 — Aug 2020 [monthly]
Completed
-
Jun 2020 — Jul 2020 [monthly]
Completed
-
Mar 2020 — Jun 2020 [monthly]
Completed
-
Oct 2019 — Mar 2020 [monthly]
Completed
-
Sep 2019 — Oct 2019 [monthly]
Completed
-
Aug 2019 — Sep 2019 [monthly]
Completed
-
Apr 2019 — Aug 2019 [monthly]
Completed
-
Mar 2019 — Apr 2019 [monthly]
Completed
-
Feb 2019 — Mar 2019 [monthly]
Completed
-
Nov 2018 — Feb 2019 [monthly]
Completed
-
Sep 2018 — Nov 2018 [monthly]
Completed
-
Jun 2018 — Sep 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Apr 1986
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .